Back

Pharma

4th Gene and Cell Therapies: CMC, CGT & Vector Manufacturing Summit

  • 19th – 20th November 2024
  • Germany flag Germany Munich

The #VLGeneCell 2024 is dedicated to accelerating progress in CMC and quality development of gene and cell therapy (GCT) products.

Discover strategies for meeting CGTP safety and efficiency criteria, regulatory and GMP manufacturing standards, and optimizing vector production processes.

Explore new technologies and processes, digital solutions and automation coupled with sophisticated CQAs, that promise to revolutionize gene and cell therapies manufacturing.

Join the forefront of gene and cell therapies at the 4th Gene and Cell Therapies: CMC, CGT & Vector Manufacturing Summit in November 2024 in Munich, Germany.

Read more

#VLGeneCell

 

Chief Executives, Vice Presidents, Directors, Heads, Leaders, and Managers specialising in:

  • Adenovirus
  • Adeno-Associated Virus (AAA)
  • Advanced Therapy Medicinal Product (ATMP)
  • Analytics
  • Analytical Science
  • Bioprocessing
  • Biotherapeutics
  • Chimeric Antigen Receptor T Cells (CAR-T)
  • Cell Engineering
  • Cell Therapy
  • Cellular Immunotherapy
  • Cellular Therapy
  • Clinical Development
  • Chemistry, Manufacturing, and Control (CMC)
  • Commercialisation
  • Comparability
  • Compliance
  • Gene Therapy
  • GMP (Good Manufacturing Practices)
  • Gene Therapy Medicinal Products (GTMPs)
  • Cell-Based Medicinal Products (CBMPs)
  • Immuno-Oncology
  • Immunology
  • Immunology Chemistry
  • Immunotherapy
  • Lentivirus (LV)
  • Manufacturing
  • Market Access
  • Medical Affairs
  • Natural Killer Cells (NK-Cells) Therapy
  • Non-Viral Vectors
  • Oncology
  • Product Characterisation
  • Process Development
  • Production Engineering
  • Quality Assurance
  • Quality Control
  • Research and Development (R&D)
  • Regenerative Medicine
  • Regulatory
  • Safety
  • Scale Up
  • Stem Cell
  • Supply Chain
  • Tumor-infiltrating lymphocytes (TILs)
  • T-Cell Receptor (TCR) Therapy
  • Viral Vector

Register by June 30

The Early Bird Offer expires in 36 days!

REQUEST A BROCHURE

To request an agenda for this Summit, please complete the details below. We will send you the agenda via email.

KEY PRACTICAL LEARNING POINTS

  • Accelerate progress in the development of gene and cell therapies (GCT), focusing on CMC and quality enhancement
  • Ensure adherence to consistent CGTP safety and efficiency standards, regulatory requirements, and GMP manufacturing protocols
  • Optimize and scale vector production processes to enhance performance and efficacy
  • Embrace new technologies and processes integrated with sophisticated CQAs to drive innovation and efficacy in GCT products

Register by June 30

The Early Bird Offer expires in 36 days!

Soon

To be announced

Soon

To be announced

Soon

To be announced

Soon

To be announced

BROCHURE

Request the 4th Gene and Cell Therapies: CMC, CGT & Vector Manufacturing brochure and find out the latest topics and ideas that will be shared.

Request

Please fill in your e-mail address below and we will process your request in a moment.

What our
participants
are saying

The #VLGeneCell was an invaluable experience. The discussions on CMC, CGT, and vector manufacturing were enlightening, providing deep insights into the latest advancements in the field. It's clear that this summit plays a pivotal role in shaping the future of gene and cell therapies.

1
2
3
4
5

PAST

Attendee

As a participant in the #VLGeenCell summit, I was impressed by the caliber of speakers and the depth of knowledge shared. The sessions on meeting regulatory standards and optimizing manufacturing processes were particularly enlightening. I left feeling inspired and equipped with new strategies to enhance our own research and development efforts.

1
2
3
4
5

PAST

Attendee

The #VLGeneCell exceeded my expectations. The diverse range of topics covered, from CMC to CGT and vector manufacturing, provided a comprehensive overview of the challenges and opportunities in the field. It was a fantastic opportunity to network with industry experts and gain valuable insights into the future of gene and cell therapies.

1
2
3
4
5

PAST

Attendee